Projects

Multicenter epidemiological study on clinical presentation of cryptococcal infections (Cryptococcosis) in patients with and without human immunodeficiency virus infection, it’s antifungal treatment and outcome in a tertiary care hospital, India

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr. Jayanthi Savio, Dr. Priyadarshini

Authors

Dr. Jayanthi Savio, Dr. Priyadarshini

Project Status

ongoing

Project Type

National FISF